These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Neuroleptic drugs in the treatment of acute psychosis: how much do we really know? Cohen BM Psychopharmacol Ser; 1988; 5():47-61. PubMed ID: 2901083 [TBL] [Abstract][Full Text] [Related]
8. Effects of sedatives and neuroleptics. Turns CN Am J Psychiatry; 1990 Nov; 147(11):1576. PubMed ID: 1977329 [No Abstract] [Full Text] [Related]
9. Atypical antipsychotics in bipolar and schizoaffective disorders. Brown ES; Thomas NR; Carmody T; Mahadi S; Nejtek VA Pharmacopsychiatry; 2001 Mar; 34(2):80-1. PubMed ID: 11302568 [TBL] [Abstract][Full Text] [Related]
10. Are the new antipsychotics no better than the classical neuroleptics? The problematic answer from the CATIE study. Möller HJ Eur Arch Psychiatry Clin Neurosci; 2005 Dec; 255(6):371-2. PubMed ID: 16382376 [No Abstract] [Full Text] [Related]
11. [Administration of high dose haloperidol in a patient refractory to treatment with traditional and atypical neuroleptics]. Stip E; Bruneau MA Encephale; 1996; 22(4):298-300. PubMed ID: 9035986 [No Abstract] [Full Text] [Related]
12. Asymmetrical effects of neuroleptics on psychotic patients' performance of a tactile discrimination task. Tomer R J Nerv Ment Dis; 1989 Nov; 177(11):699-700. PubMed ID: 2572676 [No Abstract] [Full Text] [Related]
13. Introduction. Antipsychotic agents: clinical, economic, and legal considerations in the treatment of psychosis. Lehman AF J Clin Psychiatry; 1999; 60 Suppl 19():3-4. PubMed ID: 10507274 [No Abstract] [Full Text] [Related]
14. Catechol-O-methyltransferase and monoamine oxidase-A polymorphisms and treatment response to typical and atypical neuroleptics. Nolan KA; Czobor P; Citrome LL; Krakowski M; Lachman HM; Kennedy JL; Ni X; Lieberman J; Chakos M; Volavka J J Clin Psychopharmacol; 2006 Jun; 26(3):338-40. PubMed ID: 16702905 [No Abstract] [Full Text] [Related]
15. [Psychological effects of neuroleptics (author's transl)]. Ginestet D Encephale; 1981; 7(3):225-34. PubMed ID: 6116592 [TBL] [Abstract][Full Text] [Related]
16. [Established and atypical neuroleptics. What the family physician should know]. Albus M MMW Fortschr Med; 2001 May; 143 Suppl 2():71-4. PubMed ID: 11434264 [TBL] [Abstract][Full Text] [Related]
17. Multiple versus single antipsychotic drug treatment in chronic psychosis. Godleski LS; Kerler R; Barber JW; Glick JL; Kellogg E; Vieweg WV; Yank GR J Nerv Ment Dis; 1989 Nov; 177(11):686-9. PubMed ID: 2572675 [TBL] [Abstract][Full Text] [Related]
18. Use of high-dose olanzapine in refractory psychosis. Reich J Am J Psychiatry; 1999 Apr; 156(4):661. PubMed ID: 10200755 [No Abstract] [Full Text] [Related]
19. [New "atypical" neuroleptics -- the emperor's new clothes?]. Dose M Psychiatr Prax; 2003 Jan; 30(1):1-3. PubMed ID: 12524575 [No Abstract] [Full Text] [Related]
20. Have the times come for early intervention in psychosis? Verdoux H Acta Psychiatr Scand; 2001 May; 103(5):321-2. PubMed ID: 11380301 [No Abstract] [Full Text] [Related] [Next] [New Search]